Literature DB >> 21627039

Chromatin mechanisms regulating gene expression in health and disease.

Constanze Bonifer1, Peter N Cockerill.   

Abstract

It is now well established that the interplay of sequence-specific DNA binding proteins with chromatin components and the subsequent expression of differential genetic programs is the major determinant of developmental decisions. The last years have seen an explosion of basic research that has significantly enhanced our understanding of the basic principles of gene expression control. While many questions are still open, we are now at the stage where we can exploit this knowledge to address questions of how deregulated gene expression and aberrant chromatin programming contributes to disease processes. This chapter will give a basic introduction into the principles of epigenetics and the determinants of chromatin structure and will discuss the molecular mechanisms of aberrant gene regulation in blood cell diseases, such as inflammation and leukemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21627039     DOI: 10.1007/978-1-4419-8216-2_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Conceptual shifts needed to understand the dynamic interactions of genes, environment, epigenetics, social processes, and behavioral choices.

Authors:  Fatimah L C Jackson; Mihai D Niculescu; Robert T Jackson
Journal:  Am J Public Health       Date:  2013-08-08       Impact factor: 9.308

2.  Identify gene expression pattern change at transcriptional and post-transcriptional levels.

Authors:  Ji-Gang Zhang; Chao Xu; Lan Zhang; Wei Zhu; Hui Shen; Hong-Wen Deng
Journal:  Transcription       Date:  2019-02-05

Review 3.  Functional genomics data: privacy risk assessment and technological mitigation.

Authors:  Gamze Gürsoy; Tianxiao Li; Susanna Liu; Eric Ni; Charlotte M Brannon; Mark B Gerstein
Journal:  Nat Rev Genet       Date:  2021-11-10       Impact factor: 53.242

Review 4.  Role of epigenetics in chronic myeloid leukemia.

Authors:  Katerina Machova Polakova; Jitka Koblihova; Tomas Stopka
Journal:  Curr Hematol Malig Rep       Date:  2013-03       Impact factor: 3.952

5.  RUNX1-ETO Depletion in t(8;21) AML Leads to C/EBPα- and AP-1-Mediated Alterations in Enhancer-Promoter Interaction.

Authors:  Anetta Ptasinska; Anna Pickin; Salam A Assi; Paulynn Suyin Chin; Luke Ames; Roberto Avellino; Stefan Gröschel; Ruud Delwel; Peter N Cockerill; Cameron S Osborne; Constanze Bonifer
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.423

Review 6.  Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?

Authors:  Bilal Abdulmawjood; Beatriz Costa; Catarina Roma-Rodrigues; Pedro V Baptista; Alexandra R Fernandes
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

7.  LINT, a novel dL(3)mbt-containing complex, represses malignant brain tumour signature genes.

Authors:  Karin Meier; Eve-Lyne Mathieu; Florian Finkernagel; L Maximilian Reuter; Maren Scharfe; Gunther Doehlemann; Michael Jarek; Alexander Brehm
Journal:  PLoS Genet       Date:  2012-05-03       Impact factor: 5.917

8.  Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers.

Authors:  Anuradha Illendula; Jane Gilmour; Jolanta Grembecka; Venkata Sesha Srimath Tirumala; Adam Boulton; Aravinda Kuntimaddi; Charles Schmidt; Lixin Wang; John A Pulikkan; Hongliang Zong; Mahmut Parlak; Cem Kuscu; Anna Pickin; Yunpeng Zhou; Yan Gao; Lauren Mishra; Mazhar Adli; Lucio H Castilla; Roger A Rajewski; Kevin A Janes; Monica L Guzman; Constanze Bonifer; John H Bushweller
Journal:  EBioMedicine       Date:  2016-04-29       Impact factor: 8.143

Review 9.  Role of Epigenetics in Stem Cell Proliferation and Differentiation: Implications for Treating Neurodegenerative Diseases.

Authors:  Bhairavi Srinageshwar; Panchanan Maiti; Gary L Dunbar; Julien Rossignol
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

10.  Disruption of CTCF-YY1-dependent looping of the human papillomavirus genome activates differentiation-induced viral oncogene transcription.

Authors:  Ieisha Pentland; Karen Campos-León; Marius Cotic; Kelli-Jo Davies; C David Wood; Ian J Groves; Megan Burley; Nicholas Coleman; Joanne D Stockton; Boris Noyvert; Andrew D Beggs; Michelle J West; Sally Roberts; Joanna L Parish
Journal:  PLoS Biol       Date:  2018-10-25       Impact factor: 8.029

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.